Inogen (INGN) Interest Expenses (2013 - 2022)
Inogen's (INGN) quarterly Interest Expenses came in at $12000.0 in Q3 2022, down 97.42% year-over-year from $466000.0 in Q3 2021, and down 97.42% quarter-over-quarter from $466000.0 in Q3 2021.
Powered by 
Analysis
Inogen (INGN) Interest Expenses (2013 - 2022) Analysis & Trends
Inogen (INGN) has reported Interest Expenses for 6 consecutive years, with $12000.0 the latest figure, recorded in Q3 2022.
- On a quarterly basis, Interest Expenses fell 97.42% year-over-year to $12000.0 in Q3 2022; TTM through Sep 2022 was $479000.0, a 2.13% increase from a year earlier, with the FY2016 full-year figure at $6000.0, down 72.73% from the prior year.
- Interest Expenses was $12000.0 for Q3 2022 at Inogen, down from $466000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $466000.0 in Q3 2021 and troughed at $12000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 12,000.00 |
| Sep 30, 2021 | 466,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 2,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Dec 31, 2015 | 4,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Mar 31, 2015 | 7,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 104,000.00 |
| Jun 30, 2014 | 203,000.00 |
| Mar 31, 2014 | 133,000.00 |
| Dec 31, 2013 | 250,000.00 |
| Sep 30, 2013 | 113,000.00 |
| Jun 30, 2013 | 95,000.00 |
| Mar 31, 2013 | 104,000.00 |